225 related articles for article (PubMed ID: 16424026)
1. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway.
Desai SD; Haas AL; Wood LM; Tsai YC; Pestka S; Rubin EH; Saleem A; Nur-E-Kamal A; Liu LF
Cancer Res; 2006 Jan; 66(2):921-8. PubMed ID: 16424026
[TBL] [Abstract][Full Text] [Related]
2. ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells.
Desai SD; Reed RE; Burks J; Wood LM; Pullikuth AK; Haas AL; Liu LF; Breslin JW; Meiners S; Sankar S
Exp Biol Med (Maywood); 2012 Jan; 237(1):38-49. PubMed ID: 22185919
[TBL] [Abstract][Full Text] [Related]
3. Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective.
Burks J; Reed RE; Desai SD
Oncotarget; 2015 Mar; 6(9):7221-31. PubMed ID: 25749047
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasis.
Fan JB; Arimoto K; Motamedchaboki K; Yan M; Wolf DA; Zhang DE
Sci Rep; 2015 Jul; 5():12704. PubMed ID: 26226047
[TBL] [Abstract][Full Text] [Related]
5. ISG15 as a novel tumor biomarker for drug sensitivity.
Desai SD; Wood LM; Tsai YC; Hsieh TS; Marks JR; Scott GL; Giovanella BC; Liu LF
Mol Cancer Ther; 2008 Jun; 7(6):1430-9. PubMed ID: 18566215
[TBL] [Abstract][Full Text] [Related]
6. Hepatic expression of proteasome subunit alpha type-6 is upregulated during viral hepatitis and putatively regulates the expression of ISG15 ubiquitin-like modifier, a proviral host gene in hepatitis C virus infection.
Broering R; Trippler M; Werner M; Real CI; Megger DA; Bracht T; Schweinsberg V; Sitek B; Eisenacher M; Meyer HE; Baba HA; Weber F; Hoffmann AC; Gerken G; Schlaak JF
J Viral Hepat; 2016 May; 23(5):375-86. PubMed ID: 26833585
[TBL] [Abstract][Full Text] [Related]
7. ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
Burks J; Reed RE; Desai SD
Oncogene; 2014 Feb; 33(6):794-803. PubMed ID: 23318454
[TBL] [Abstract][Full Text] [Related]
8. A novel role for ATM in regulating proteasome-mediated protein degradation through suppression of the ISG15 conjugation pathway.
Wood LM; Sankar S; Reed RE; Haas AL; Liu LF; McKinnon P; Desai SD
PLoS One; 2011 Jan; 6(1):e16422. PubMed ID: 21298066
[TBL] [Abstract][Full Text] [Related]
9. The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: friend or foe?
Andersen JB; Hassel BA
Cytokine Growth Factor Rev; 2006 Dec; 17(6):411-21. PubMed ID: 17097911
[TBL] [Abstract][Full Text] [Related]
10. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein.
Zhao C; Beaudenon SL; Kelley ML; Waddell MB; Yuan W; Schulman BA; Huibregtse JM; Krug RM
Proc Natl Acad Sci U S A; 2004 May; 101(20):7578-82. PubMed ID: 15131269
[TBL] [Abstract][Full Text] [Related]
11. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15.
Okumura A; Lu G; Pitha-Rowe I; Pitha PM
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1440-5. PubMed ID: 16434471
[TBL] [Abstract][Full Text] [Related]
12. ISG15 inhibits cancer cell growth and promotes apoptosis.
Zhou MJ; Chen FZ; Chen HC; Wan XX; Zhou X; Fang Q; Zhang DZ
Int J Mol Med; 2017 Feb; 39(2):446-452. PubMed ID: 28035359
[TBL] [Abstract][Full Text] [Related]
13. Proteasomes modulate conjugation to the ubiquitin-like protein, ISG15.
Liu M; Li XL; Hassel BA
J Biol Chem; 2003 Jan; 278(3):1594-602. PubMed ID: 12426315
[TBL] [Abstract][Full Text] [Related]
14. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer.
Bektas N; Noetzel E; Veeck J; Press MF; Kristiansen G; Naami A; Hartmann A; Dimmler A; Beckmann MW; Knüchel R; Fasching PA; Dahl E
Breast Cancer Res; 2008; 10(4):R58. PubMed ID: 18627608
[TBL] [Abstract][Full Text] [Related]
16. [Advances in ubiquitin-like protein ISG15-mediated anti-viral response].
Zhu ZX; Wei JC; Shi ZX; Wu KB; Ma ZY
Bing Du Xue Bao; 2012 Jan; 28(1):78-83. PubMed ID: 22416355
[TBL] [Abstract][Full Text] [Related]
17. ISG15 pathway knockdown reverses pancreatic cancer cell transformation and decreases murine pancreatic tumor growth via downregulation of PDL-1 expression.
Burks J; Fleury A; Livingston S; Smith JP
Cancer Immunol Immunother; 2019 Dec; 68(12):2029-2039. PubMed ID: 31709456
[TBL] [Abstract][Full Text] [Related]
18. The ubiquitin-like molecule interferon-stimulated gene 15 is overexpressed in human prostate cancer.
Satake H; Tamura K; Furihata M; Anchi T; Sakoda H; Kawada C; Iiyama T; Ashida S; Shuin T
Oncol Rep; 2010 Jan; 23(1):11-6. PubMed ID: 19956859
[TBL] [Abstract][Full Text] [Related]
19. Camptothecin induces the ubiquitin-like protein, ISG15, and enhances ISG15 conjugation in response to interferon.
Liu M; Hummer BT; Li X; Hassel BA
J Interferon Cytokine Res; 2004 Nov; 24(11):647-54. PubMed ID: 15684817
[TBL] [Abstract][Full Text] [Related]
20. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
